These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31541198)

  • 1. From New directions in immuno-oncology.
    Romero D
    Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in the global immuno-oncology landscape.
    Tang J; Pearce L; O'Donnell-Tormey J; Hubbard-Lucey VM
    Nat Rev Drug Discov; 2018 Nov; 17(11):783-784. PubMed ID: 30337722
    [No Abstract]   [Full Text] [Related]  

  • 3. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customer pyramid framework for CAR T-cell therapies in immuno-oncology.
    Malik NN; Durdy MB
    Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical development of immuno-oncology in China.
    Wu DW; Huang HY; Tang Y; Zhao Y; Yang ZM; Wang J; Wang SH; Yu Y; Fang Y; Fang H; Bai Y; Sun C; Fan Q; Yu AQ; Wang HL; Du CX; Chen K; Huang MD; Zhang Y; Li N; Xu BH; Sun Y; He J
    Lancet Oncol; 2020 Aug; 21(8):1013-1016. PubMed ID: 32758460
    [No Abstract]   [Full Text] [Related]  

  • 6. [New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
    Champiat S; Soria JC
    Med Sci (Paris); 2017; 33(6-7):563-564. PubMed ID: 28990546
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction.
    Reardon DA; Weller M
    Neuro Oncol; 2015 Nov; 17 Suppl 7(Suppl 7):vii1. PubMed ID: 26516220
    [No Abstract]   [Full Text] [Related]  

  • 8. [The revolution of immuno-oncology therapy: specificities for the physicians].
    Dubois M; Ardin C; André F; Scherpereel A; Mortier L
    Med Sci (Paris); 2019 Dec; 35(12):946-948. PubMed ID: 31903898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).
    Guo ZS
    BMC Cancer; 2018 Nov; 18(1):1086. PubMed ID: 30415640
    [No Abstract]   [Full Text] [Related]  

  • 10. [New immunological concepts in oncology].
    Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
    [No Abstract]   [Full Text] [Related]  

  • 11. SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art.
    Butterfield LH; Disis ML; Fox BA; Kaufman DR; Khleif SN; Wang E;
    J Immunother Cancer; 2018 Dec; 6(1):138. PubMed ID: 30514399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer treatment of today in view of the Nobel Prize.
    Ullenhag G
    Ups J Med Sci; 2018 Dec; 123(4):205-206. PubMed ID: 30526172
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy].
    Caux C
    Bull Cancer; 2020 Jan; 107(1):6-9. PubMed ID: 31954504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany.
    Quandt D; Seliger B
    Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolution of interventional oncology in the 21st century.
    Helmberger T
    Br J Radiol; 2020 Sep; 93(1113):20200112. PubMed ID: 32706978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial (Thematic Issue: Clinical Advances in Immuno-oncology - Progress Towards Selective Cure).
    Liu X; Belani CP
    Curr Mol Pharmacol; 2016; 9(3):182. PubMed ID: 26177639
    [No Abstract]   [Full Text] [Related]  

  • 17. Desperation Oncology.
    Fojo T
    Semin Oncol; 2018 Jun; 45(3):105-106. PubMed ID: 30301565
    [No Abstract]   [Full Text] [Related]  

  • 18. Host immunity ignored in clinical oncology: a medical opinion.
    Elliott RL; Head JF
    Cancer Biother Radiopharm; 2005 Apr; 20(2):123-5. PubMed ID: 15869445
    [No Abstract]   [Full Text] [Related]  

  • 19. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
    Maio M; Coukos G; Ferrone S; Fox BA; Fridman WH; Garcia PL; Lahn M; Provendier O; Russo V; Rüttinger D; Shalabi A; Trajanoski Z; Viallet J; Wolchok JD; Ibrahim R
    Cancer Immunol Immunother; 2019 Jan; 68(1):1-9. PubMed ID: 30564889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The future of oncology has begun].
    Stiefelhagen P
    MMW Fortschr Med; 2016 Jun; 158(12):16. PubMed ID: 27323979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.